FundedIQ
Biotechnology

YGION Biomedical: Funding, Investors & Team (Nov 2026)

Austria's YGION Biomedical is dedicated to turning personalized cancer immunotherapy into a viable option.

www.ygion.bio LinkedIn Austria, Philippines 1-10 employees
Biotechnology Oncology Therapeutics B2C
Total raised
$16.3M
Rounds
1
Latest
Series A
May 2024

YGION Biomedical has raised $16.3M across 1 funding round on record, the most recent a Series A of $16.3M announced in May 2024.

That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

YGION Biomedical Company Profile and Key Stats

Total funding raised
$16.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$16.3M in May 2024
Employees
1-10
reported band
Headquarters
Austria, Philippines

Latest funding round on record: May 2024.

YGION Biomedical Funding Rounds

Date
Round
Amount
Series A
$16.3M

YGION Biomedical Founders and Leadership Team

Name
Role
Contact
Gottfried Himmler
Founder
—

No contact details are on record for this team yet.

YGION Biomedical Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
98
$6.0M
8,738
$15M

YGION Biomedical's latest round of $16.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like YGION Biomedical in Biotechnology and Austria

Companies Similar to YGION Biomedical

Preventix, created by the Mexican research laboratory Timser, is a novel screening test that uses a minimally…

Seed $3.5M

Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered…

Series A $34.0M

Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…

Seed $4.5M

VectorY utilizes a combination of antibodies and gene therapy to create effective and long-lasting treatments…

Undisclosed round $83.2M

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

Pre-Seed $5.3M

Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…

Series B $25.0M

Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…

Undisclosed round $380k

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…

Series C $100M

It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed…

Seed $35.1M

altM's goal is to create and produce scalable biomaterials that can assist major industries in decreasing…

Series A $10.3M

The Company's corporate purpose is: I) the development of new high-value biotechnological solutions based on…

Undisclosed round $2.3M

Venomics AI is a drug discovery platform using venom peptides for therapeutics.

Pre-Seed $2.7M

YGION Biomedical Funding FAQs

What does YGION Biomedical do?

Austria's YGION Biomedical is dedicated to turning personalized cancer immunotherapy into a viable option.

How much funding has YGION Biomedical raised?

YGION Biomedical has raised $16.3M across 1 round on record. The most recent is a Series A of $16.3M announced in May 2024.

When did YGION Biomedical last raise funding?

YGION Biomedical's most recent funding round on record is a Series A of $16.3M, announced in May 2024.

Who founded YGION Biomedical?

FundedIQ lists Gottfried Himmler (Founder) at YGION Biomedical.

Where is YGION Biomedical headquartered?

YGION Biomedical is based in Austria, Pangasinan, Philippines.

How many employees does YGION Biomedical have?

YGION Biomedical is in the 1-10 employee band.

How does YGION Biomedical's funding compare to other Biotechnology startups?

YGION Biomedical's latest round of $16.3M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's YGION Biomedical Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for YGION Biomedical is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.